Skip to content

Clinical trials

Recruiting Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Recruiting Country / region: Russia Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20211
20221
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
St. Petersburg State Pavlov Medical University3
Novartis Pharmaceuticals2
Ascentage Pharma Group Inc.1
Il-Yang Pharm. Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive7
Leukemia, Myeloid, Acute3
Myelodysplastic Syndromes3
Leukemia, Myeloid, Chronic-Phase2
Myeloproliferative Disorders2
Blast Crisis1
Graft vs Host Disease1
Leukemia, Biphenotypic, Acute1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative1
Lymphoma, Non-Hodgkin1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.